There's no guarantee that there even are further broad spectrum antibiotics possible.
As far as I understand, what's needed here is (first) fundamental research, then discussion of promising ideas, then maybe you can rely on private companies to perfect and bring to market new molecules.
Thats a far cry from other drugs for other diseases where there is a futile set of fundamentals to pick over and small research groups spinning off from universities regulatly.
Every time I've heard of new prospects, it's either been reexamining old methods (like plagues) or new fundamental work (sampling and sequencing new bacteria, studies on fungi).
So instead of "incentives", we should just man up and fund some biology and stop wasting what we have already on farm animal fattening programs and the worried well etc.
As far as I understand, what's needed here is (first) fundamental research, then discussion of promising ideas, then maybe you can rely on private companies to perfect and bring to market new molecules.
Thats a far cry from other drugs for other diseases where there is a futile set of fundamentals to pick over and small research groups spinning off from universities regulatly.
Every time I've heard of new prospects, it's either been reexamining old methods (like plagues) or new fundamental work (sampling and sequencing new bacteria, studies on fungi).
So instead of "incentives", we should just man up and fund some biology and stop wasting what we have already on farm animal fattening programs and the worried well etc.